AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.

Revenue
+6.03%
EPS
−73.9%
Free cash flow
−16.9%
Total debt
+14.6%

Quarter to September 2026, against a year earlier

143.84 3.02 −2.06%
Market cap
$9.1B
P/E
34.6×
Fwd P/E
25.9×
Dividend yield
1.00%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

20.43 21.32 22.36 29.13
P/S ratio
2.12 2.08 2.03 1.93
P/FCF ratio
26.90 24.56 25.33 26.09
P/Operating CF
43.65 68.00 76.99 45.92
P/B ratio
2.99 3.05 3.01 2.92
EV/Sales
2.41 2.38 2.32 2.22
EV/EBITDA
11.53 11.62 11.65 11.32
EV/FCF
30.50 28.02 29.05 30.03
Current Ratio
1.62 1.66 1.61 1.50
Net Debt/EBITDA
5.87 6.20 5.67 5.52
Debt/Equity
0.55 0.52 0.52 0.52
Earnings Yield
4.90% 4.69% 4.47% 3.43%
Free Cash Flow Yield
3.72% 4.07% 3.95% 3.83%
Free Cash Flow per Share
1.48 0.84 0.74 1.52
Book value per Share
40.86 41.34 41.59 41.45
Free Cash Flow
97.60 54.03 46.93 96.46
EV/EBIT
18.14 18.60 19.14 18.63
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026